TSX:CRDL (Canada)  
Cardiol Therapeutics Inc logo

Cardiol Therapeutics Inc

C$ 1.28 (+4.92%) Oct 6
P/E:
At Loss
P/B:
1.26
Market Cap:
C$ 79.29M ($ 57.72M)
Enterprise V:
C$ 8.93M ($ 6.50M)
Volume:
154.76K
Avg Vol (2M):
144.16K
Also Trade In:
Volume:
154.76K
Market Cap C$:
79.29M
Market Cap $:
57.72M
PE Ratio:
At Loss
Avg Vol (2-Month):
144.16K
Enterprise Value C$:
8.93M
Enterprise Value $:
6.50M
PB Ratio:
1.26
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in Phase II/III study, the LANCER trial. The CardiolRx is also being investigated in patients with acute myocarditis and recurrent pericarditis.
Name Current Vs Industry Vs History
Cash-To-Debt 733.9
Equity-to-Asset 0.85
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36
9-Day RSI 37.26
14-Day RSI 39.55
6-1 Month Momentum % -31.92
12-1 Month Momentum % -65.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.48
Quick Ratio 6.48
Cash Ratio 6.2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.7

Financials (Next Earnings Date:2022-11-15 Est.)

TSX:CRDL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0
EPS (TTM) (C$) -0.55
Beta 0.56
Volatility % 41.05
14-Day RSI 39.55
14-Day ATR (C$) 0.117383
20-Day SMA (C$) 1.4805
12-1 Month Momentum % -65.8
52-Week Range (C$) 1.2 - 6.11
Shares Outstanding (Mil) 61.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cardiol Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Cardiol Therapeutics Inc Analysis

Share your research